Home › Funds › Elevate Capital Advisors, LLC › SGOL

Elevate Capital Advisors, LLC position in SGOL

ABERDEEN STD GOLD ETF TR PHYSICAL SWISS GOLD SHS ETF

Elevate Capital Advisors, LLC reported holding 20,310 shares of SGOL (ABERDEEN STD GOLD ETF TR PHYSICAL SWISS GOLD SHS ETF) in its Q2 2026 13F filing — a position valued at US$776K, representing 0.43% of its reported portfolio and ranking #42 among its reported holdings. Elevate Capital Advisors, LLC has disclosed SGOL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)20.31K sh
Reported value held$776.45K
Portfolio Weight0.43%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Elevate Capital Advisors, LLC's SGOL position evolved

Elevate Capital Advisors, LLC first disclosed a stake in SGOL in Q4 2024 at 28,302 shares (US$709K). The position peaked in Q3 2025 at 56,697 shares, worth US$2.1M. Across 7 filings, Elevate Capital Advisors, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 20,310 shares valued at US$776K — a reduction of -8,937 shares quarter over quarter.. Notable position changes include a 43% increase in Q2 2025 (shares rose 17% over the following quarter), a 41% trim in Q1 2026 (shares fell 14% over the following quarter), a 31% trim in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 28.30K $708.97K New
Q1 2025 33.38K $995.30K Add
Q2 2025 47.82K $1.51M Add
Q3 2025 56.70K $2.09M Add
Q4 2025 49.66K $2.04M Reduce
Q1 2026 29.25K $1.31M Reduce
Q2 2026 20.31K $776.45K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SGOL and 13F data

SGOL (ABERDEEN STD GOLD ETF TR PHYSICAL SWISS GOLD SHS ETF) is a company whose sector is not yet classified in our data. 33 other funds we track also report a position in SGOL — the largest reported positions include Metis Global Partners, LLC (US$297.9M), Almanack Investment Partners, LLC. (US$40.2M), Ethos Financial Group, LLC (US$35.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SGOL

All SGOL fund holders →

FAQ

How long has Elevate Capital Advisors, LLC held SGOL?

Elevate Capital Advisors, LLC has disclosed SGOL holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Elevate Capital Advisors, LLC's current position in SGOL?

As of Q2 2026, Elevate Capital Advisors, LLC holds 20.31K shares of SGOL (ABERDEEN STD GOLD ETF TR PHYSICAL SWISS GOLD SHS ETF), valued at $776.45K, representing 0.43% of its reported portfolio and ranking #42.

Has Elevate Capital Advisors, LLC been buying or selling SGOL?

In the latest 13F filing (Q2 2026), Elevate Capital Advisors, LLC reduced its position in SGOL. The position peaked in Q3 2025 at 56.70K shares.

Which other funds hold SGOL?

Other major institutional holders of SGOL include Metis Global Partners, LLC, Almanack Investment Partners, LLC., Ethos Financial Group, LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.